Dr Park Young Jin
Dr. Youngjin Park is the President of Obliv Clinic Network in Incheon and Bangkok, and serves as the Chief International Academic Director for both the Korean Aesthetic Surgery & Laser Society (ASLS) and the Korean Academy of Facelifting and Contouring (KAFC).
A graduate of Inha University College of Medicine, Dr. Park completed an executive program at Seoul National University and previously served as a Public Doctor for the Korean Government. His clinical expertise includes facial rejuvenation (HA, CaHA, PLLA, PDLLA, PCL), thread lifting and SMAS anatomy, energy-based aesthetic devices (RF, HIFU, laser, microwave), and regenerative aesthetic medicine (exosomes, PN, stem cell derivatives).
Dr. Park is a Global Key Opinion Leader (KOL) and Academic Brand Manager for multiple international medical aesthetics companies, including Wontech, Merz, Dexlevo, Humedix, and VAIM Global. He has been an invited speaker at major international congresses such as IMCAS Asia, AMWC Taipei, ASLS Bangkok, MEVOS Xi’an, and AMSC Malaysia.
He has published extensively in peer-reviewed journals including Antioxidants, Diagnostics, Polymers, Journal of Cosmetic Dermatology, and International Journal of Molecular Sciences, with notable contributions in exosome therapy, filler safety zones, and biomaterial development. Dr. Park is recognized globally for advancing evidence-based and anatomically precise approaches in aesthetic and regenerative medicine.